Literature DB >> 16220223

Intravenous application of omega-3 fatty acids in a patient with active spondylarthropathy--a case report.

Christian Fassl1, Judith Sautner, Bernhard Rintelen, Burkhard F Leeb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16220223     DOI： 10.1007/s10067-005-0027-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

Review 1.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 2.  n-3 fatty acid supplements in rheumatoid arthritis.

Authors:  J M Kremer
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

3.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

Review 4.  Anti-TNF therapy and malignancy - a critical review.

Authors:  R B Cohen; K A Dittrich
Journal:  Can J Gastroenterol       Date:  2001-06       Impact factor: 3.522

5.  Functional changes in patients with spondylarthropathy. A controlled trial of the effects of short-term rehabilitation and 3-year follow-up.

Authors:  J V Viitanen; S Heikkilä
Journal:  Rheumatol Int       Date:  2001-07       Impact factor: 2.631

6.  Effects of fish oil supplementation in rheumatoid arthritis.

Authors:  H van der Tempel; J E Tulleken; P C Limburg; F A Muskiet; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

7.  Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis.

Authors:  D Volker; P Fitzgerald; G Major; M Garg
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

8.  Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates.

Authors:  J M Kremer; D A Lawrence; G F Petrillo; L L Litts; P M Mullaly; R I Rynes; R P Stocker; N Parhami; N S Greenstein; B R Fuchs
Journal:  Arthritis Rheum       Date:  1995-08
  8 in total
  1 in total

1.  Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study.

Authors:  Burkhard F Leeb; Judith Sautner; Ingrid Andel; Bernhard Rintelen
Journal:  Lipids       Date:  2006-01       Impact factor: 1.880
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.